Validation of the T86I mutation in the gyrA gene as a highly reliable real time PCR target to detect Fluoroquinolone-resistant Campylobacter jejuni

BMC Infectious Diseases
Nereyda EspinozaMark P Simons

Abstract

Campylobacter jejuni is a leading cause of bacterial diarrhea worldwide, and increasing rates of fluoroquinolone (FQ) resistance in C. jejuni are a major public health concern. The rapid detection and tracking of FQ resistance are critical needs in developing countries, as these antimicrobials are widely used against C. jejuni infections. Detection of point mutations at T86I in the gyrA gene by real-time polymerase chain reaction (RT-PCR) is a rapid detection tool that may improve FQ resistance tracking. C. jejuni isolates obtained from children with diarrhea in Peru were tested by RT-PCR to detect point mutations at T86I in gyrA. Further confirmation was performed by sequencing of the gyrA gene. We detected point mutations at T86I in the gyrA gene in 100% (141/141) of C. jejuni clinical isolates that were previously confirmed as ciprofloxacin-resistant by E-test. No mutations were detected at T86I in gyrA in any ciprofloxacin-sensitive isolates. Detection of T86I mutations in C. jejuni is a rapid, sensitive, and specific method to identify fluoroquinolone resistance in Peru. This detection approach could be broadly employed in epidemiologic surveillance, therefore reducing time and cost in regions with limited resources.

References

Jul 1, 1992·Diagnostic Microbiology and Infectious Disease·C N Baker
Oct 23, 1997·International Journal of Systematic Bacteriology·P VandammeS L On
Apr 3, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·B M Allos
May 11, 2002·The Journal of Antimicrobial Chemotherapy·S ChatzipanagiotouN I Legakis
May 7, 2003·Applied and Environmental Microbiology·Beilei GeJianghong Meng
Jan 17, 2007·International Journal of Antimicrobial Agents·Alfred Dieudonné KinanaJean-David Perrier-Gros-Claude
Nov 23, 2007·FEMS Microbiology Letters·David A Alfredson, Victoria Korolik
Mar 1, 2008·International Journal of Antimicrobial Agents·Anna FàbregaJordi Vila
Oct 22, 2008·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Gulibahaer BakeliNoboru Okamura
Nov 4, 2010·Journal of Infection in Developing Countries·Mayar M SaidMohamed S Salama
Dec 3, 2010·Current Opinion in Gastroenterology·Beth D Kirkpatrick, David R Tribble
Dec 9, 2010·Tropical Medicine & International Health : TM & IH·Kathleen HollowayUNKNOWN Community-Based Surveillance of Antimicrobial Use and Resistance in Resource-Constrained Settings Project Group
Dec 9, 2010·Tropical Medicine & International Health : TM & IH·Kathleen HollowayUNKNOWN Community-Based Surveillance of Antimicrobial Use and Resistance in Resource-Constrained Settings Project Group
Apr 22, 2011·BMC Infectious Diseases·Anita Kotwani, Kathleen Holloway
May 4, 2011·Revista peruana de medicina experimental y salud pública·Heriberto Fernández
Aug 18, 2012·BMC Infectious Diseases·Simon PollettMatthew Kasper
Aug 25, 2012·Frontiers in Cellular and Infection Microbiology·Jing HanQijing Zhang
Feb 6, 2013·PLoS Neglected Tropical Diseases·Gwenyth LeeMargaret Kosek
Nov 2, 2014·The Pediatric Infectious Disease Journal·Gwenyth LeeMargaret Kosek
Feb 8, 2018·PLoS Neglected Tropical Diseases·Ruthly FrançoisMargaret N Kosek

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Software Mentioned

AlleleID

Related Concepts

Related Feeds

Campylobacteriosis (ASM)

Campylobacteriosis is caused by the bacteria Campylobacter jejuni and is a common cause of gastroenteritis in humans. Discover the latest research on Campylobacteriosis here.